Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
TrumpRx lists many medicines at prices higher than paid in UK
02:23pm, Wednesday, 18'th Mar 2026
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those
Big drugmakers must face US overcharge claims on medications for low-income patients
02:32pm, Tuesday, 17'th Mar 2026
A U.S. appeals court on Tuesday revived a whistleblower lawsuit accusing four large drugmakers of defrauding the federal and state governments out of hundreds of millions of dollars by overcharg
AstraZeneca's Imfinzi Secures Approval for Gastric Cancer in the EU
11:35am, Tuesday, 17'th Mar 2026
AZN wins the EU nod for Imfinzi in early gastric and GEJ cancers, backed by strong survival data and expanding its blockbuster oncology footprint.
Astrazeneca Plc $AZN Shares Purchased by Bamco Inc. NY
06:08am, Monday, 16'th Mar 2026
Bamco Inc. NY increased its holdings in Astrazeneca Plc (NYSE: AZN) by 9.4% in the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 140,008 shares of the company
Ameriprise Financial Inc. Boosts Stock Position in Astrazeneca Plc $AZN
03:26am, Monday, 16'th Mar 2026
Ameriprise Financial Inc. boosted its stake in shares of Astrazeneca Plc (NYSE: AZN) by 13.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission.
AstraZeneca's Imfinzi Gets EU Approval for Treatment of Early Gastric Cancer
02:58am, Monday, 16'th Mar 2026
Imfinzi is approved in the EU to treat early-stage gastric and gastroesophageal cancers in combination with chemotherapy.
Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline
06:46am, Thursday, 12'th Mar 2026
British drugmaker AstraZeneca Plc (NYSE: AZN) has emerged as the leading contender to acquire French biotech Abivax SA (NASDAQ: ABVX), following the company's dramatic valuation surge after strong cli
Diversify Advisory Services LLC Sells 3,043 Shares of AstraZeneca PLC $AZN
04:12am, Wednesday, 11'th Mar 2026
Diversify Advisory Services LLC lowered its stake in shares of AstraZeneca PLC (NASDAQ: AZN) by 12.8% during the undefined quarter, according to its most recent disclosure with the Securities and Exch
AstraZeneca (LON:AZN) Stock Price Crosses Above 200-Day Moving Average – Here’s What Happened
02:56am, Wednesday, 11'th Mar 2026
AstraZeneca PLC (LON: AZN - Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of £133.11 and traded as high as £147.9
AstraZeneca and Joshua Jackson partner to encourage fans to Get Body Checked Against Cancer
08:30am, Tuesday, 10'th Mar 2026
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Joshua Jackson have teamed up as part of a national public health campaign designed to encourage fans to Get Body Checked Against Cancer and be proac
Cresset Asset Management LLC Lowers Holdings in AstraZeneca PLC $AZN
05:42am, Tuesday, 10'th Mar 2026
Cresset Asset Management LLC trimmed its stake in AstraZeneca PLC (NASDAQ: AZN) by 25.8% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commissi
Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term
10:51am, Friday, 06'th Mar 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Jefferies raises AstraZeneca target to 18,000p as analysts flip view on delayed cancer trial
07:19am, Friday, 06'th Mar 2026
Broker upgrades odds on AVANZAR lung cancer trial after arguing repeated delays signal strong results in treatment arm Jefferies has lifted its price target on AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), t
Jefferies raises AstraZeneca target to 18,000p as analysts flip view on delayed cancer trial
07:17am, Friday, 06'th Mar 2026
Broker upgrades odds on AVANZAR lung cancer trial after arguing repeated delays signal strong results in treatment arm Jefferies has lifted its price target...
Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term
10:40am, Thursday, 05'th Mar 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
